MedPath

Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy

Phase 3
Conditions
Hypertrophic Cardiomyopathy
Interventions
Device: Cardiac Resynchronisation Therapy
Registration Number
NCT00698074
Lead Sponsor
University Hospital Birmingham
Brief Summary

The primary aim of this study will be to assess whether Biventricular pacing improves exercise capacity, and Quality of Life in patients with symptomatic drug resistant Non-Obstructive Hypertrophic Cardiomyopathy, using a Biventricular pacemaker.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Symptomatic Hypertrophic Cardiomyopathy,
Exclusion Criteria
  • Rhythm other than normal sinus Left ventricular outflow tract gradient greater than 30mmHg Inability to exercise v02 max greater than 70% of predicted.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department Cardiovascular Medicine, University of Birmingham

🇬🇧

Birmingham, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath